Integrated Annual Report

Overview

The report describes UCB's 2018 progress toward becoming a patient-preferred biopharma leader through its Patient Value Strategy, supported by growth in core medicines and revenue of € 4.6 billion. The company set 2030 environmental goals to reduce carbon emissions by 35%, become carbon neutral, cut water consumption by 20% and reduce waste production by 25%. It also reports 7 495 employees, no work-related fatalities, and broad community and patient-access initiatives. Selected ESG data and the GRI Standards claim were subject to PwC limited assurance.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2018
Period: Ends 31 December 2018
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services